Form 4: GoodRx Holdings Chief Accounting Officer Reports Stock Transactions
SEC Form 4 Filing
Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, reports the vesting and disposal of restricted stock units and shares of Class A common stock.
Summary
- On April 15, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., had 2,606 restricted stock units vest, which were then converted into Class A common stock.
- Nabiey also disposed of 930 shares of Class A Common Stock to cover tax obligations at a price of $6.83 per share.
- Following these transactions, Nabiey directly owns 117,673 shares of Class A Common Stock and 7,818 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting stock transactions. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 04/15/2021 | 19% of restricted stock units vested. |
| 04/15/2024 | Vesting of 2,606 restricted stock units and disposal of 930 shares for tax obligations. |
| 04/16/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.